Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Point of Care Molecular Diagnostics Market: By Application, By End User, and Region Forecast 2019-2030
Point of Care Molecular Diagnostics Market: By Application, By End User, and Region Forecast 2019-2030
Point of Care Molecular Diagnostics Market size was valued at US$ 3.28 billion in 2023 growing at a CAGR of 9.1% from 2024-2030. The market is fuelled by some of the key factors such as rising demand for rapid diagnostics, increasing prevalence of infectious diseases, technological advancements, and growing awareness of healthcare. The high cost of tests, Regulatory hurdles, and Limited test menu are the restraints that need to be addressed for the market growth. There is a significant opportunity for market growth which is the development of multiplex tests, integration with digital health technologies, and expansion into new applications. Focus on user-friendliness, miniaturization of devices, and point-of-need testing are the trends that help in the market growth.
North America currently holds the dominant position & Asia Pacific region is expected to witness the fastest growth in the market. Traditional laboratory-based molecular diagnostics often have long turnaround times, which can delay treatment decisions. PoC molecular diagnostics offer results in minutes, enabling faster and more effective treatment. The global burden of infectious diseases is high, and the demand for rapid and accurate diagnostics is growing. PoC molecular diagnostics can be used to diagnose a wide range of infectious diseases, including COVID-19, influenza, and sexually transmitted infections (STIs). Advancements in molecular diagnostics technologies, such as microfluidics and isothermal amplification, are leading to the development of smaller, faster, and more user-friendly PoC molecular diagnostic tests. There is a growing awareness of healthcare among the population, which is leading to an increased demand for self-testing and home healthcare products. PoC molecular diagnostics can be used for self-testing and home healthcare, which can improve access to diagnostics for people in remote areas or with limited healthcare resources.
Study Period
2024-2030Base Year
2023CAGR
9.1%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Multiplex PoC molecular diagnostic tests can detect multiple pathogens simultaneously, which can improve diagnostic accuracy and efficiency. PoC molecular diagnostic tests can be integrated with digital health technologies, such as telemedicine, to allow for remote monitoring and treatment. PoC molecular diagnostics can be used for a variety of applications beyond infectious disease testing, such as cancer diagnostics, pharmacogenomics, and personalized medicine. PoC molecular diagnostic tests are becoming increasingly user-friendly, making them easier to use by healthcare professionals and patients alike. PoC molecular diagnostic devices are becoming smaller and more portable, making them more convenient for use in a variety of settings.
There is a growing trend towards point-of-need testing (PON testing), which refers to the use of diagnostic tests at the location where the patient needs care. PON testing can improve access to diagnostics in resource-limited settings. The PoC Molecular Diagnostics Market is a rapidly growing market with significant potential for future growth. The drivers mentioned above are expected to continue to propel the market forward, while the restraints and opportunities will shape the future of the market. PoC molecular diagnostic tests can be expensive, which can limit their adoption in low- and middle-income countries. The development and approval of new PoC molecular diagnostic tests can be a lengthy and expensive process. The number of PoC molecular diagnostic tests available is currently limited compared to traditional laboratory-based tests.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America currently holds the dominant position in the PoC Molecular Diagnostics market, accounting for over half of the global market share. This lead can be attributed to the presence of major market players, high healthcare expenditure, and well-established healthcare infrastructure in the region. Europe is another prominent market for PoC Molecular Diagnostics, driven by factors like rising government funding for healthcare initiatives and increasing adoption of advanced technologies.
The Asia Pacific region is expected to witness the fastest growth in the PoC Molecular Diagnostics market during the forecast period. This growth is attributed to the burgeoning economies, rising disposable incomes, and growing investments in the healthcare sector in this region. Latin America, the Middle East, and Africa represent emerging markets for PoC Molecular Diagnostics. The growth in these regions is expected to be driven by factors like increasing government initiatives to improve healthcare infrastructure and growing awareness of advanced diagnostic techniques.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
9.1% |
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global poc molecular diagnostics market size was valued at US$ 3.28 billion in 2023 and is projected to grow at a CAGR of 9.1% from 2024 to 2030.
Rising demand for rapid diagnostics, increasing prevalence of infectious diseases, technological advancements, and growing awareness of healthcare
Asia-Pacific is the fastest-growing region in the market.
Focus on user-friendliness, miniaturization of devices, and point-of-need testing are the trends in the market.
| 1.Executive Summary |
| 2.Global Point of Care Molecular Diagnostics Market Introduction |
| 2.1.Global Point of Care Molecular Diagnostics Market - Taxonomy |
| 2.2.Global Point of Care Molecular Diagnostics Market - Definitions |
| 2.2.1.Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3.Global Point of Care Molecular Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Point of Care Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Point of Care Molecular Diagnostics Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Infectious Diseases, |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Oncology, |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Hematology, |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Prenatal Testing, |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Endocrinology and |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Other Applications |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Point of Care Molecular Diagnostics Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Decentralized Labs |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospitals |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Home-care |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Assisted Living Healthcare Facilities |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Other users |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Point of Care Molecular Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Point of Care Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Infectious Diseases, |
| 8.1.2.Oncology, |
| 8.1.3.Hematology, |
| 8.1.4.Prenatal Testing, |
| 8.1.5.Endocrinology and |
| 8.1.6.Other Applications |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Decentralized Labs |
| 8.2.2.Hospitals |
| 8.2.3.Home-care |
| 8.2.4.Assisted Living Healthcare Facilities |
| 8.2.5.Other users |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Point of Care Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Infectious Diseases, |
| 9.1.2.Oncology, |
| 9.1.3.Hematology, |
| 9.1.4.Prenatal Testing, |
| 9.1.5.Endocrinology and |
| 9.1.6.Other Applications |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Decentralized Labs |
| 9.2.2.Hospitals |
| 9.2.3.Home-care |
| 9.2.4.Assisted Living Healthcare Facilities |
| 9.2.5.Other users |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Point of Care Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Infectious Diseases, |
| 10.1.2.Oncology, |
| 10.1.3.Hematology, |
| 10.1.4.Prenatal Testing, |
| 10.1.5.Endocrinology and |
| 10.1.6.Other Applications |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Decentralized Labs |
| 10.2.2.Hospitals |
| 10.2.3.Home-care |
| 10.2.4.Assisted Living Healthcare Facilities |
| 10.2.5.Other users |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Infectious Diseases, |
| 11.1.2.Oncology, |
| 11.1.3.Hematology, |
| 11.1.4.Prenatal Testing, |
| 11.1.5.Endocrinology and |
| 11.1.6.Other Applications |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Decentralized Labs |
| 11.2.2.Hospitals |
| 11.2.3.Home-care |
| 11.2.4.Assisted Living Healthcare Facilities |
| 11.2.5.Other users |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Point of Care Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Infectious Diseases, |
| 12.1.2.Oncology, |
| 12.1.3.Hematology, |
| 12.1.4.Prenatal Testing, |
| 12.1.5.Endocrinology and |
| 12.1.6.Other Applications |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Decentralized Labs |
| 12.2.2.Hospitals |
| 12.2.3.Home-care |
| 12.2.4.Assisted Living Healthcare Facilities |
| 12.2.5.Other users |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott Laboratories |
| 13.2.2.Danaher Corporation |
| 13.2.3.Biomerieux Sa |
| 13.2.4.Roche Diagnostics |
| 13.2.5.Quidel |
| 13.2.6.Meridian Bioscience |
| 13.2.7.Mesa Biotech |
| 13.2.8.Genepoc |
| 13.2.9.DxNA |
| 13.2.10.Atlas Genetics |
| 13.2.11.Spartan Bioscience |
| 13.2.12.Biocartis |
| 13.2.13.Becton, Dickinson and Company (BD) |
| 13.2.14.Bio-Rad Laboratories |
| 13.2.15.Cepheid |
| 13.2.16.Johnson & Johnson |
| 13.2.17.OraSure Technologies |
| 13.2.18.QuantuMDx Group |
| 13.2.19.Siemens Healthineers |
| 13.2.20.Sysmex Corp. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.